Goxalapladib is a 5-HT 6 receptor modulator that blocks lipoprotein-associated phospholipase A2 ( Lp-PLA2 ) activity. Goxalapladib is promising for research of atherosclerosis-associated cardiovascular diseases.
Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > 5-HT Receptor | Products > Signaling Pathways > Phospholipase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.